The use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: Oncology clinics at Northern and Southern Turkey

dc.contributor.authorBayındır Çevik, Ayfer
dc.contributor.authorAkinci, Ayse Cil
dc.contributor.authorBaglama, Sevgin Samancioglu
dc.contributor.authorÇevik, Ayfer Bayındır
dc.date.accessioned2025-10-18T13:25:01Z
dc.date.created2019
dc.date.issued2019
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümü
dc.description.abstractPurpose: This study aimed to determine the prevalence and predictors of the use of Complementary and Alternative Medicine (CAM) and to examine the differences between patients who used CAM and those who did not among those who were being treated in oncology clinics in the northern and southern regions of Turkey. In order to collect the relevant data, 288 outpatients receiving chemotherapy were selected to participate in the study. Materials and methods: The research was designed as a descriptive, relational and cross-sectional study. Data was collected by the researchers using a form which had already been developed in the literature. Results: As a result of our study, we found that 33.2% of the patients had stage 4 cancer and 22.9% of them had respiratory system cancer. The most commonly used form of CAM was herbal preparations, which were used by 48.4% and around 31 species of herbs were employed. 59.1% of the patients used CAM to support their conventional treatment. The prevalence of the CAM usage was determined as 32.3%. Conclusion: Even though a wide range of different forms of CAM are currently used by oncology patients in the northern and southern regions of Turkey, further cooperation with health professionals is needed to obtain better information about both CAM usage and medical treatment. Better informing patients about how best to use CAM in conjunction with medical treatment is also crucial.
dc.identifier.doi10.1016/j.ctim.2019.08.007
dc.identifier.issn0965-2299
dc.identifier.issn1873-6963
dc.identifier.pmid31780026
dc.identifier.scopus2-s2.0-85075406605
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ctim.2019.08.007
dc.identifier.urihttps://hdl.handle.net/11772/23236
dc.identifier.volume47
dc.identifier.wosWOS:000501643500019
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherChurchill Livingstone
dc.relation.ispartofComplementary Therapies in Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectComplementary And Alternative Medicine
dc.subjectSolid Tumor
dc.subjectCancer Patient
dc.subjectTurkey
dc.titleThe use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: Oncology clinics at Northern and Southern Turkey
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationa170374a-b120-4d2d-b2eb-27ac83a19a85
relation.isAuthorOfPublication.latestForDiscoverya170374a-b120-4d2d-b2eb-27ac83a19a85

Dosyalar